Latest Revenue Growth News

Alfabs Australia reported a 28% revenue rise to $55.6 million in H1 2026, but EBITDA fell due to a $2.8 million Dartbrook mine impact and softer engineering margins. The company is investing heavily in mining hire assets and pursuing a strategic acquisition to drive future growth.

IMDEX Limited has reported its strongest first half ever, with revenue climbing 16% to $247 million, driven by robust market share gains and key acquisitions that broaden its mining technology portfolio.

Cash Converters International Limited reported an 8% rise in half-year revenue to $206.7 million, driven by franchise acquisitions and a shift in lending strategy. Despite a 17% dip in net profit due to one-off costs, the company declared a fully franked interim dividend and reinstated its Dividend Reinvestment Plan.

McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.

thl reports an 11% rise in underlying NPAT for H1 FY26 and sets a bullish FY26 guidance, underpinned by strategic divestments and cost efficiencies.

Chorus Limited has reported a strong half-year performance driven by fibre broadband growth, operational efficiencies, and a return to profitability, while launching initiatives to boost digital inclusion.

N1 Holdings Limited reported a robust 64.7% increase in net profit after tax to $1.04 million for the half-year ended December 2025, driven by strong commercial lending growth and operational efficiencies. The company also expanded its committed lending capacity to over $355 million while maintaining a stable dividend.

Murray Cod Australia has appointed Steven Chaur as its new Managing Director and CEO, aiming to accelerate revenue growth and operational efficiency from April 2026. The move signals a strategic push to deepen domestic channels and expand the luxury fish brand’s market presence.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

BSP Financial Group has reported a robust 12.9% increase in net profit for 2025, underpinned by strong revenue growth and strategic restructuring, including converting its Fiji branch into a wholly owned subsidiary.

LGI Limited reported robust half-year results for December 2025, showcasing strong revenue and profit growth alongside operational expansion and strategic debt repayment.

Qube Holdings reported a robust half-year performance for FY26, with underlying revenue climbing 12.9% and a significant property sale boosting statutory profits. The company also announced a major acquisition agreement with Macquarie Asset Management, signaling a transformative phase ahead.